Scientific Article
previous document  unige:144215  next document
add to browser collection
Title

Precision and prognostic value of clone-specific minimal residual disease in acute myeloid leukemia

Authors
Hirsch, Pierre
Tang, Ruoping
Abermil, Nassera
Flandrin, Pascale
Moatti, Hannah
Favale, Fabrizia
Suner, Ludovic
Lorre, Florence
show hidden authors show all authors [1 - 18]
Published in Haematologica. 2017, vol. 102, no. 7, p. 1227-1237
Abstract The genetic landscape of adult acute myeloid leukemias (AML) has been recently unraveled. However, due to their genetic heterogeneity, only a handful of markers are currently used for the evaluation of minimal residual disease (MRD). Recent studies using multi-target strategies indicate that detection of residual mutations in less than 5% of cells in complete remission is associated with a better survival. Here, in a series of 69 AMLs with known clonal architecture, we design a clone-specific strategy based on fluorescent in situ hybridization and high-sensitivity next generation sequencing to detect chromosomal aberrations and mutations, respectively, in follow-up samples. The combination of these techniques allows tracking chromosomal and genomic lesions down to 0.5-0.4% of the cell population in remission samples. By testing all lesions in follow-up samples from 65 of 69 evaluable patients, we find that initiating events often persist and appear to be, on their own, inappropriate markers to predict short-term relapse. In contrast, the persistence of two or more lesions in more than 0.4% of the cells from remission samples is strongly associated with lower leukemia-free and overall survivals in univariate and multivariate analyses. Although larger prospective studies are needed to extend these results, our data show that a personalized, clone-specific, MRD follow up strategy is feasible in the vast majority of AML cases.
Keywords AdolescentAdultAgedAged, 80 and overAllelesBiomarkers, TumorChromosome AberrationsClonal Evolution/geneticsFemaleHigh-Throughput Nucleotide SequencingHumansIn Situ HybridizationFluorescenceLeukemia, Myeloid, Acute/diagnosis/genetics/mortalityMaleMiddle AgedMutationNeoplasm, Residual/diagnosis/geneticsPrecision MedicinePrognosisYoung Adult
Identifiers
PMID: 28302711
Full text
Article (Published version) (3.4 MB) - public document Free access
Research group Leucémie et transplantation allogénique de cellules souches hématopoïétiques (982)
Citation
(ISO format)
HIRSCH, Pierre et al. Precision and prognostic value of clone-specific minimal residual disease in acute myeloid leukemia. In: Haematologica, 2017, vol. 102, n° 7, p. 1227-1237. doi: 10.3324/haematol.2016.159681 https://archive-ouverte.unige.ch/unige:144215

22 hits

11 downloads

Update

Deposited on : 2020-11-05

Export document
Format :
Citation style :